Drugmakers Biogen and AbbVie said they are pulling their new multiple-sclerosis treatment Zinbryta from all global markets after several European patients suffered serious inflammatory brain disorders.
from WSJ.com: US Business http://ift.tt/2I0UGrd
via IFTTT
No comments:
Post a Comment